BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 9672336)

  • 1. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects.
    Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Kitadai Y; Komoto K; Tanaka S; Kajiyama G
    Am J Gastroenterol; 1998 Jul; 93(7):1090-6. PubMed ID: 9672336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation of serum pepsinogen level and gastric mucosal changes of residents in the high incidence area of gastric cancer].
    Zhang XH; Huang B; Wang JL; Li YH; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):507-11. PubMed ID: 17147114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q; Ran ZH; Xiao SD
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.
    Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Tanaka S; Kajiyama G; Shigenobu T
    Hiroshima J Med Sci; 1997 Jun; 46(2):81-6. PubMed ID: 9232936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the cut-off value of serum pepsinogen abnormality for screening chronic atrophic gastritis and gastric carcinoma].
    Li YH; Zhang XH; Huang B; Wang JL; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Oct; 27(10):840-4. PubMed ID: 17343174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].
    Sun LP; Gong YH; Wang L; Gong W; Yuan Y
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2826-30. PubMed ID: 17200016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the validity of three biomarkers for gastric cancer screening: carcinoembryonic antigen, pepsinogens, and high sensitive C-reactive protein.
    Chung HW; Kim JW; Lee JH; Song SY; Chung JB; Kwon OH; Lim JB
    J Clin Gastroenterol; 2009 Jan; 43(1):19-26. PubMed ID: 18648315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
    Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
    Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma pepsinogens, nutrients, and diet in areas of Italy at varying gastric cancer risk.
    Palli D; Decarli A; Cipriani F; Forman D; Amadori D; Avellini C; Giacosa A; Manca P; Russo A; Salkeld RM
    Cancer Epidemiol Biomarkers Prev; 1991; 1(1):45-50. PubMed ID: 1845168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative colonoscopy for patients with gastric adenocarcinoma.
    Kim HO; Hwang SI; Yoo CH; Kim H
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1740-4. PubMed ID: 19686412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of serum pepsinogen levels and quininium resin test combined for gastric cancer screening.
    Kim JR; Lee K; Jung WT; Lee OJ; Kim TH; Kim HJ; Lee JS; Passaro DJ
    Cancer Detect Prev; 2005; 29(6):570-5. PubMed ID: 16289505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up study on a high risk population of gastric cancer in north China by serum pepsinogen assay.
    Sun LP; Gong YH; Wang L; Gong W; Yuan Y
    J Dig Dis; 2008 Feb; 9(1):20-6. PubMed ID: 18251790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
    Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The significance of pepsinogen with its subgroup and CA72-4 associate detect applied to early diagnostic and prognosis judgment on gastric cancer].
    Lin HZ; Chen L; Li XC; Zhou DF; Cui JY
    Zhonghua Wai Ke Za Zhi; 2004 Dec; 42(24):1505-8. PubMed ID: 15733483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum pepsinogens in relation to precancerous gastric lesions in a population at high risk for gastric cancer.
    You WC; Blot WJ; Zhang L; Kneller RW; Li JY; Jin ML; Chang YS; Zeng XR; Zhao L; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 1993; 2(2):113-7. PubMed ID: 8467245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
    Onoda N; Katsuragi K; Maeda K; Sawada T; Wakasa K; Hirakawa K
    Hepatogastroenterology; 2006; 53(70):619-23. PubMed ID: 16995475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are the serum biomarkers pepsinogen I and II good predictors for the detection of subjects with atrophic gastritis in areas that have different gastric cancer incidence?
    Mohamadkhani A; Darvish Moghaddam S; Salmanroghani H; Allafsghari A; Yazdanbod A; Mirzaei M; Haj-sheykholeslami A; Bashiri J; Sadjadi A; Massarrat S
    Arch Iran Med; 2013 Apr; 16(4):208-12. PubMed ID: 23496362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg.
    Roman LD; Lukyanchuk R; Sablin OA; Araslanova EI; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
    Anticancer Res; 2016 Aug; 36(8):4129-38. PubMed ID: 27466521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma.
    Sugiu K; Kamada T; Ito M; Kaya S; Tanaka A; Kusunoki H; Hata J; Haruma K
    Dig Liver Dis; 2006 May; 38(5):303-7. PubMed ID: 16549394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.